Mesoblast Limited American Depositary Shares MESO
i
Market datapartial · fetched 2026-11-12T03:10:03.793Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T23:27:19.963630959Z
FundamentalsAlpha Vantage · unavailable
Mesoblast Limited American Depositary Shares options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 9.63 | 615.9% | 47.8% | |||
| 25Δ | 10.95 | 502.5% | 38.2% | |||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | 13.55 | 308.3% | 19.4% | |||
| 45Δ | ||||||
| 50Δ | 14.79 | 274.7% | 22.3% | |||
| 55Δ | 14.28 | 300.5% | 21.3% | |||
| 60Δ | 13.56 | 291.5% | 17.6% | 15.20 | 183.9% | 7.2% |
| 65Δ | 12.75 | 247.8% | 12.0% | 15.44 | 165.2% | 5.7% |
| 70Δ | 12.17 | 214.0% | 8.1% | 15.68 | 146.5% | 4.2% |
| 75Δ | 11.74 | 190.2% | 5.6% | 15.92 | 127.8% | 2.8% |
| 80Δ | 11.37 | 170.5% | 3.9% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 9.63
- IV
- 615.9%
- B/E move
- 47.8%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 10.95
- IV
- 502.5%
- B/E move
- 38.2%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 13.55
- IV
- 308.3%
- B/E move
- 19.4%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 14.79
- IV
- 274.7%
- B/E move
- 22.3%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 14.28
- IV
- 300.5%
- B/E move
- 21.3%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 13.56
- IV
- 291.5%
- B/E move
- 17.6%
- Pseudo strike
- 15.20
- IV
- 183.9%
- B/E move
- 7.2%
65Δ
- Pseudo strike
- 12.75
- IV
- 247.8%
- B/E move
- 12.0%
- Pseudo strike
- 15.44
- IV
- 165.2%
- B/E move
- 5.7%
70Δ
- Pseudo strike
- 12.17
- IV
- 214.0%
- B/E move
- 8.1%
- Pseudo strike
- 15.68
- IV
- 146.5%
- B/E move
- 4.2%
75Δ
- Pseudo strike
- 11.74
- IV
- 190.2%
- B/E move
- 5.6%
- Pseudo strike
- 15.92
- IV
- 127.8%
- B/E move
- 2.8%
80Δ
- Pseudo strike
- 11.37
- IV
- 170.5%
- B/E move
- 3.9%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 143.38% | |
| 140.93% | |
| 135.51% | |
| 138.64% | |
| 145.12% | |
| 148.41% | |
| 141.07% | |
| 139.44% | |
| 109.47% | |
| 122.69% |
Biotechnology
MGNX
MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapies to treat cancer in the United States. The company is headquartered in Rockville,…
More →MGTX
MeiraGTx Holdings plc, a clinical-stage gene therapy company, focused on developing treatments for patients living with serious illnesses. The company is headquartered in New…
More →MIRM
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies for debilitating liver…
More →MIST
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular drugs. The company is headquartered in Montral,…
More →MLTX
Description unavailable
More →MLYS
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. The…
More →